Intraindividual comparison of 123I-mIBG SPECT/MRI, 123I-mIBG SPECT/CT, and MRI for the detection of adrenal pheochromocytoma in patients with elevated urine or plasma catecholamines

Clinical Nuclear Medicine

Volumn 38, Issue 10, 2013, Pages 810-

  Ilias, Ioannis ^a   Meristoudis, Georgios ^b  

^a E Venizelou Hospital   (Greece)

^b Henri Dunant Hospital   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; CATECHOLAMINE; (3 IODOBENZYL)GUANIDINE; DIAGNOSTIC AGENT;

ADRENAL TUMOR; CATECHOLAMINE BLOOD LEVEL; COMPUTER ASSISTED TOMOGRAPHY; GENETIC DISORDER; HUMAN; LETTER; NUCLEAR MAGNETIC RESONANCE IMAGING; PHEOCHROMOCYTOMA; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; BLOOD; DIAGNOSTIC USE; FEMALE; MALE; SCINTISCANNING; URINE; NOTE;

3-IODOBENZYLGUANIDINE; CATECHOLAMINES; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; PHEOCHROMOCYTOMA; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84897583853     PISSN: 03639762     EISSN: 15360229     Source Type: Journal    
DOI: 10.1097/RLU.0b013e31829f8e7d     Document Type: Letter

References (7)

1. Derlin T, Busch JD,Wisotzki C, et al. Intraindividual comparison of 123I-mIBG SPECT/MRI, 123I-mIBG SPECT/CT, and MRI for the detection of adrenal pheochromocytoma in patients with elevated urine or plasma catecholamines. Clin Nucl Med. 2013; 38:e1-e6.
2. Chen H, Sippel RS, Pacak K. The NANETS consensus guideline for the diagnosis and management of neuroendocrine tumors: pheochromocytoma, paraganglioma & medullary thyroid cancer. Pancreas. 2010;39:775-783.
3. Ilias I, Divgi C, Pacak K. Current role of MIBG in the diagnosis of pheochromocytoma and medullary thyroid cancer. Semin Nucl Med. 2011;41: 364-368.
4. Fonte JS, Robles JF, Chen CC, et al. False-negative 123I-MIBG SPECT is most commonly found in SDHB-related pheochromocytoma or paraganglioma with high frequency to develop metastatic disease. Endocr Relat Cancer. 2012;19:83-93.
5. Bhatia KS, Ismail MM, Sahdev A, et al. 123IMetaiodobenzylguanidine (MIBG) scintigraphy for the detection of adrenal and extra-adrenal phaeochromocytomas: CT and MRI correlation. Clin Endocrinol (Oxf ). 2008;69:181-188.
6. Fottner C,Helisch A, Anlauf M, et al. 6-18F-fluoro- L- dihydroxyphenylalanine positron emission tomography is superior to 123I-metaiodobenzyl-guanidine scintigraphy in the detection of extraadrenal and hereditary pheochromocytomas and paragangliomas: correlation with vesicular monoamine transporter expression. J Clin Endocrinol Metab. 2010;95: 2800-2810.
7. Ilias I, Carrasquillo JA, Chen CC, et al. Superiority of 6-[18F]-fluorodopamine positron emission tomography versus [131I]- metaiodobenzylguanidine scintigraphy in the localization of metastatic pheochromocytoma. J Clin Endocrinol Metab. 2003;88: 4083-4087.